Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2024-09-27 00:00:00 ET · period of report 2024-09-25 · accession 0000950170-24-110141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-09-27 | 2024-09-25 | WVE | Moran Kyle | CFO | S - Sale | $9.00 | -17.1K | 19.8K | -46% | -$154.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-09-25 | S | D | 17,146 | $9.00 | 19,777 | D | — | — | (F2) Includes 3,002 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan. |